Alivus Life Sciences Limited

Direct answer

Alivus Life Sciences Limited is publicly traded on NSE under the ticker ALIVUS.NS.

Alivus Life Sciences Limited, a Mumbai, India-headquartered entity established in 2001, operates as a subsidiary of Nirma Limited. Having rebranded from Glenmark Life Sciences Limited in December 2024, the company specializes in the development, production, and global commercialization of active pharmaceutical ingredients (APIs). Its market footprint spans India, Japan, Europe, and both North and Latin America,...

Can you invest in Alivus Life Sciences Limited?

Yes. Alivus Life Sciences Limited trades publicly on NSE as ALIVUS.NS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Alivus Life Sciences Limited

Detailed equity research is provided by MarketSnap.